[1] |
Stucken EZ, Brown K, Selesnick SH. Clinical and diagnostic evaluation of acoustic neuromas[J]. Otolaryngol Clin North Am, 2012, 45(2): 269-284, vii.
|
[2] |
Yamakami I, Kobayashi E, Iwadate Y, et al. Hypervascular vestibular schwannomas[J]. Surg Neurol, 2002, 57(2): 105-112.
|
[3] |
Teranishi Y, Kohno M, Sora S, et al. Hypervascular vestibular schwannomas: clinical characteristics, angiographical classification, and surgical considerations[J]. Oper Neurosurg (Hagerstown), 2018, 15(3): 251-261.
|
[4] |
李龄,雷霆,韩林.富含血管的听神经瘤[J].中华神经外科杂志, 2007, 23(4): 243-245.
|
[5] |
Perneczky A. Blood supply of acoustic neurinomas[J]. Acta Neurochir (Wien), 1980, 52(3-4): 209-218.
|
[6] |
Tanaka Y, Kohno M, Hashimoto T, et al. Arterial spin labeling imaging correlates with the angiographic and clinical vascularity of vestibular schwannomas[J]. Neuroradiology, 2020, 62(4): 463-471.
|
[7] |
Curtin HD, Hirsch WL Jr. Imaging of acoustic neuromas. 1992[J]. Neurosurg Clin N Am, 2008, 19(2): 175-205, v.
|
[8] |
Strasilla C, Sychra V. Imaging-based diagnosis of vestibular schwannoma[J]. Hno, 2017, 65(5): 373-380.
|
[9] |
Bergamino M, Bonzano L, Levrero F, et al. A review of technical aspects of T1-weighted dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in human brain tumors[J]. Phys Med, 2014, 30(6): 635-643.
|
[10] |
Oto A, Yang C, Kayhan A, et al. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis[J]. AJR Am J Roentgenol, 2011, 197(6): 1382-1390.
|
[11] |
Roberts HC, Roberts TP, Brasch RC, et al. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade[J]. AJNR Am J Neuroradiol, 2000, 21(5): 891-899.
|
[12] |
Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols[J]. J Magn Reson Imaging, 1999, 10(3): 223-232.
|
[13] |
Berman RM, Brown AM, Chang SD, et al. DCE MRI of prostate cancer[J]. Abdom Radiol (NY), 2016, 41(5): 844-853.
|
[14] |
Benshoff ER, Katz BH. Ectopia of the posterior pituitary gland as a normal variant: assessment with MR imaging[J]. AJNR Am J Neuroradiol, 1990, 11(4): 709-712.
|
[15] |
Kim LJ, Lekovic GP, White WL, et al. Preliminary experience with 3-tesla MRI and Cushing’s disease[J]. Skull Base, 2007, 17(4): 273-277.
|
[16] |
刘佩芳,鲍润贤,牛昀,等.乳腺良恶性病变动态增强MRI表现特征与血管生成相关性的初步研究[J].中华放射学杂志, 2002, 36(11): 967-972.
|
[17] |
王霄英,杨德文,蒋学祥. MRI动态增强扫描对垂体微腺瘤的诊断意义[J].中国医学影像技术, 2000, 16(4): 262.
|
[18] |
Takahashi M, Okudera T, Tomanaga M, et al. Angiographic diagnosis of acoustic neurinomas: analysis of 30 lesions[J]. Neuroradiology, 1971, 2(4): 191-200.
|
[19] |
Isebaert S, De Keyzer F, Haustermans K, et al. Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology[J]. Eur J Radiol, 2012, 81(3): e217-e222.
|
[20] |
Puech P, Potiron E, Lemaitre L, et al. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens[J]. Urology, 2009, 74(5): 1094-1099.
|
[21] |
Liu HL, Zong M, Wei H, et al. Differentiation between malignant and benign breast masses: combination of semi-quantitative analysis on DCE-MRI and histogram analysis of ADC maps[J]. Clin Radiol, 2018, 73(5): 460-466.
|
[22] |
Kim SH, Choi MS, Kim MJ, et al. Role of semi-quantitative dynamic contrast-enhanced MR imaging in characterization and grading of prostate cancer[J]. Eur J Radiol, 2017, 94: 154-159.
|
[23] |
Padhani AR, Husband JE. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies[J]. Clin Radiol, 2001, 56(8): 607-620.
|
[24] |
Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI[J]. Magn Reson Med, 2002, 47(3): 601-606.
|